Piramal Pharma Solutions
Rory Curtis is a seasoned biotechnology and pharmaceutical professional with extensive leadership experience spanning over two decades. Currently serving as AVP & Global Head of Discovery Services at Piramal Pharma Solutions since 2025, Rory has built a diverse portfolio that includes ownership of Rory Curtis Biotech Consulting, which supports various stakeholders in the biopharmaceutical sector. Previously held pivotal roles as Vice President of Business Development at Symeres and Aragen Life Sciences, as well as Vice President of US Commercial Operations at Metrion Biosciences and at Hauptman-Woodward Medical Research Institute. Rory's past positions also include Vice President of Drug Discovery and Vice President of Discovery Biology and Pharmacology at AMRI, and Senior Director of Discovery Biology at Cubist Pharmaceuticals. Educational credentials include a PhD in Biochemistry and Neurobiology, and a BSc degree in Biochemistry and Zoology from Imperial College London.
This person is not in any teams
This person is not in any offices
Piramal Pharma Solutions
3 followers
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.